Cargando…

Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma

Immunotherapy for lung adenocarcinoma (LUAD) is considered to be a promising treatment option, but only a minority of patients benefit from it. Therefore, it is essential to clarify the regulation mechanism of the tumor immune microenvironment (TIM) of the LUAD. Receptor-type protein tyrosine phosph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhimin, Zhang, Jinjun, Liu, Biqiong, Hong, Zhiqian, Chen, Zengguang, Huang, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934981/ https://www.ncbi.nlm.nih.gov/pubmed/36816740 http://dx.doi.org/10.1155/2023/5248897

Ejemplares similares

PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma
por: Gan, Jinfeng, et al.
Publicado: (2020)

PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer
por: Hou, Xuben, et al.
Publicado: (2021)

PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
por: Zhang, Wenjie, et al.
Publicado: (2015)

PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
por: Dong, Hongmei, et al.
Publicado: (2022)

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance
por: Dong, Hongmei, et al.
Publicado: (2022)

Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma
por: Pan, Ya-Qiang, et al.
Publicado: (2022)

Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma
por: Ming, Fei, et al.
Publicado: (2017)

Study on the Relationship Between PTPRO Methylation in Plasma and Efficacy Neoadjuvant Chemotherapy in Patients with Early Breast Cancer
por: Liu, Xiang-Wei, et al.
Publicado: (2023)

Comprehensive analysis of clinical prognosis and CLIC1 immune invasion in lung adenocarcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2022)

Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma
por: Zhou, Yang, et al.
Publicado: (2023)

A Comprehensive and Systematic Analysis Revealed the Role of ADAR1 in Pan-Cancer Prognosis and Immune Implications
por: Zhu, Jianlin, et al.
Publicado: (2023)

PTPRO knockdown protects against inflammation in hemorrhage shock-induced lung injury involving the NF-κB signaling pathway
por: Huan, Zhirong, et al.
Publicado: (2022)

PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2
por: Dong, H, et al.
Publicado: (2017)

Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma
por: Li, Xuedong, et al.
Publicado: (2023)

Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma
por: Zhou, Xiuzhi, et al.
Publicado: (2018)

CRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitro
por: Stepanek, Laurie, et al.
Publicado: (2001)

Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma
por: Ma, Yi, et al.
Publicado: (2021)

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
por: Li, Shao-ying, et al.
Publicado: (2014)

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
por: Huang, Yi-Teng, et al.
Publicado: (2013)

MiR-6869-5p Induces M2 Polarization by Regulating PTPRO in Gestational Diabetes Mellitus
por: Wang, Pingping, et al.
Publicado: (2021)

Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
por: Yao, Zhimeng, et al.
Publicado: (2023)

Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma
por: Wu, Minle, et al.
Publicado: (2022)

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma
por: Li, Yanqi, et al.
Publicado: (2021)

Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma
por: Chen, Mengqing, et al.
Publicado: (2022)

Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma
por: Xu, Zhiquan, et al.
Publicado: (2022)

Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma
por: Wu, Dabin, et al.
Publicado: (2022)

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
por: Sun, Sijin, et al.
Publicado: (2021)

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
por: Zeng, Zhimin, et al.
Publicado: (2022)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Retraction for Motiwala et al., Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer
Publicado: (2022)

Significance of Spliceosome-Related Genes in the Prediction of Prognosis and Treatment Strategies for Lung Adenocarcinoma
por: Yang, Ying, et al.
Publicado: (2022)

The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
por: Asbagh, Layka Abbasi, et al.
Publicado: (2014)

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2022)

Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma
por: Li, Fangfang, et al.
Publicado: (2022)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_su53prbdstdobnlk4mfb4vvl0h